The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

Clinical trial NCT02503280 · WITHDRAWN

Trial details

NCT number: NCT02503280
Sponsor: Joshua M Hare
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Ischemic Left Ventricular Dysfunction Myocardial Infarction

Start date: 2025-03-01
Primary completion: 2030-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.